# Aarden Pharmaceuticals, Inc. — Form D/A

Aarden Pharmaceuticals, Inc. of INDIANAPOLIS, IN, a company, filed a Form D amendment with the SEC on 2011-01-03. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-01-03
- Form: D/A
- Accession: 0001507273-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $500K
- Amount sold: $500K
- Minimum investment: $250K
- Investors: 2
- Date of first sale: 2010-11-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-151550

## Issuer

- Name: Aarden Pharmaceuticals, Inc.
- CIK: 0001507273
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 351 W. 10TH STREET, SUITE 248, INDIANAPOLIS, IN, 46202
- Phone: 317-690-2453

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Thomas M Estok | Director | Carlsbad, CA |
| Christopher C LeMasters | Director | San Diego, CA |
| Gary M Noonan | Director | Indianapolis, IN |
| Zhong Yin Zhang | Director | Indianapolis, IN |
| Francis J Burrows | Executive Officer | San Diego, CA |
| Gary M Noonan | Executive Officer | Indianapolis, IN |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-12-08](https://search.stillhousedata.com/formd/0001507273-10-000001) | D | $250K | $250K |

## More

- [CIK 1507273 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1507273&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001507273-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.